(Q40114214)

17 September 2017

1 reference

title

Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure (English)

1 reference

17 September 2017

0 references

congestive heart failure

1 reference

2

R N Brogden

1 reference

17 September 2017

J A Romankiewicz

1

1 reference

17 September 2017

R C Heel

series ordinal

3

1 reference

17 September 2017

T M Speight

series ordinal

4

1 reference

17 September 2017

G S Avery

series ordinal

5

1 reference

17 September 2017

1 January 1983

1 reference

17 September 2017

1 reference

17 September 2017

25

1 reference

17 September 2017

6-40

1 reference

17 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198325010-00002

17 September 2017

0 references

cites work

Long-term treatment of congestive heart failure by captopril: hemodynamic, biological and clinical effects

1 reference

12 December 2020

Captopril-associated lymphadenopathy

1 reference

12 December 2020

Blood concentration and urinary excretion of captopril (SQ 14,225) in patients with chronic renal failure

1 reference

12 December 2020

Nephrotic syndrome in patient on captopril

1 reference

12 December 2020

Antinuclear and antinative DNA antibodies during captopril treatment

1 reference

12 December 2020

Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension

1 reference

12 December 2020

Hemodynamic and radionuclide effects of acute captopril therapy for heart failure: changes in left and right ventricular volumes and function at rest and during exercise

1 reference

12 December 2020

Medical intelligence drug therapy: captopril

1 reference

12 December 2020

The effects of meclofenamate, captopril and phentolamine on organ blood flow in the conscious rabbit.

1 reference

12 December 2020

Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.

1 reference

12 December 2020

Cardioaccelerator action of angiotensin

1 reference

12 December 2020

Disposition of captopril in normal subjects

1 reference

12 December 2020

Hepatitis associated with captopril treatment

1 reference

12 December 2020

In vitro biotransformations of [14C]captopril in the blood of rats, dogs and humans

1 reference

12 December 2020

Hyperplasia of juxtaglomerular cells and renin localization in kidney of normotensive animals given captopril. Electron microscopic and immunohistochemical studies

1 reference

12 December 2020

Capoten-induced juxtaglomerular hyperplasia in rabbits

1 reference

12 December 2020

Membranous glomerulopathy in a patient on captopril

1 reference

12 December 2020

Proteinuria during long-term captopril therapy

1 reference

12 December 2020

Renal Vasodilator Responses to Captopril in Dogs Pretreated with Indomethacin

1 reference

12 December 2020

Ulceration of the tongue: a complication of captopril therapy

1 reference

12 December 2020

Effect of food on the bioavailability of captopril in healthy subjects

1 reference

12 December 2020

Neurohumoral control mechanisms in congestive heart failure

1 reference

12 December 2020

The effects of captopril (SQ 14,225) on bradykinin-induced bronchoconstriction in the anesthetized guinea pig

1 reference

12 December 2020

Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure

1 reference

12 December 2020

Inhibition of central angiotensin I conversion by oral captopril

1 reference

12 December 2020

Eosinophilia during captopril treatment

1 reference

12 December 2020

Angiotensin converting enzyme inhibition in patients with congestive heart failure

1 reference

12 December 2020

Aphthous ulcers of mouth from captopril

1 reference

12 December 2020

Aldosterone and its regulation during diuresis in patients with gross congestive heart failure

1 reference

12 December 2020

Captopril therapy for severe CHF: hypotensive response in presence of markedly elevated PRA

1 reference

12 December 2020

Fatal Pancytopenia Associated with the Use of Captopril

1 reference

12 December 2020

Renin, aldosterone and cardiac decompensation: Studies with an oral converting enzyme inhibitor in heart failure

1 reference

12 December 2020

The renin-angiotensin system (first of two parts).

1 reference

12 December 2020

Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study

1 reference

12 December 2020

Angiotensin II is more potent than potassium in regulating aldosterone in cardiac failure: evidence during captopril therapy

1 reference

12 December 2020

Hyponatraemia in congestive heart failure during treatment with captopril

1 reference

12 December 2020

Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy

1 reference

12 December 2020

Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure

1 reference

12 December 2020

Potentiation of the morphine-induced respiratory rate depression by captopril

1 reference

12 December 2020

Renin-Angiotensin System

1 reference

12 December 2020

Effect of beta adrenergic blockade on renin response to renal nerve stimulation

1 reference

12 December 2020

Long-term hemodynamic and clinical efficacy of captopril therapy in ambulatory management of severe chronic congestive heart failure

1 reference

12 December 2020

Renal handling of captopril: effect of probenecid

1 reference

12 December 2020

Pityriasis rosea-like rash from captopril

1 reference

12 December 2020

Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

1 reference

12 December 2020

Acute renal failure, hemolytic anemia and skin rash associated with captopril therapy

1 reference

12 December 2020

Effect of captopril on renal function in patients with congestive heart failure

1 reference

12 December 2020

Long-term control of congestive heart failure with captopril

1 reference

12 December 2020

Haemodynamic and myocardial metabolic effects of captopril in chronic heart failure

1 reference

12 December 2020

Captopril-induced agranulocytosis in systemic sclerosis

1 reference

12 December 2020

Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure

1 reference

12 December 2020

Neurological dysfunction in two patients receiving captopril and cimetidine

1 reference

12 December 2020

Haemodynamic effects of dobutamine in patients with congestive heart failure receiving captopril

1 reference

12 December 2020

Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor

1 reference

12 December 2020

Exfoliative dermatitis from captopril

1 reference

12 December 2020

Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting Enzyme

1 reference

12 December 2020

Postural hypotension during tilt with chronic captopril and diuretic therapy of severe congestive heart failure

1 reference

12 December 2020

Immune complex glomerulopathy and captopril

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition in congestive heart failure: The concept

1 reference

12 December 2020

Captopril (SQ 14225) clearance during hemodialysis treatment.

1 reference

12 December 2020

Low-dose captopril in chronic heart failure: acute haemodynamic effects and long-term treatment

1 reference

12 December 2020

The effect of captopril (SQ14,225) upon mother and fetus in the chronically cannulated ewe and in the pregnant rabbit.

1 reference

12 December 2020

Captopril-associated neutropenia. Who is at risk?

1 reference

12 December 2020

Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy

1 reference

12 December 2020

Severe hyponatraemia and cardiac failure successfully treated with captopril.

1 reference

12 December 2020

Captopril-associated agranulocytosis

1 reference

12 December 2020

Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.

1 reference

12 December 2020

Sympathetic responsiveness and plasma norepinephrine during therapy of chronic congestive heart failure with captopril

1 reference

12 December 2020

Immune and toxic mechanisms in drug-induced agranulocytosis.

1 reference

12 December 2020

Mechanism of captopril-induced agranulocytosis

1 reference

12 December 2020

Captopril in human blood and breast milk

1 reference

12 December 2020

Captopril-Induced Skin Eruptions

1 reference

12 December 2020

Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition and prostaglandins

1 reference

12 December 2020

Does captopril cause renal damage in hypertensive patients? Report from the Captopril Collaborative Study Group

1 reference

12 December 2020

Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure

1 reference

12 December 2020

Haemodynamic, hormonal, and electrolyte responses to withdrawal of long-term captopril treatment for heart failure

1 reference

12 December 2020

Hemodynamic and metabolic effects of vasodilators, nitrates, hydralazine, prazosin and captopril in chronic ischemic heart failure

1 reference

12 December 2020

The renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Effect of angiotensin I converting enzyme inhibitor SQ 14225 (Captopril)

1 reference

12 December 2020

Acute haemodynamic and hormonal effects of captopril are diminished by indomethacin

1 reference

12 December 2020

The renin-angiotensin system (second of two parts)

1 reference

12 December 2020

Improvement of chronic congestive heart-failure by oral captopril

1 reference

12 December 2020

The Effects of Captopril, Propranolol, and Indomethacin on Blood Pressure and Plasma Renin Activity in Spontaneously Hypertensive and Normotensive Rats

1 reference

12 December 2020

The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation

1 reference

12 December 2020

Nephrotic syndrome during captopril therapy

1 reference

12 December 2020

Congestive heart failure in normotensive man. Haemodynamics, renin, and angiotensin II blockade

1 reference

12 December 2020

In vitro studies on the metabolic pathway of SQ 14225 (Captopril) and mechanism of mixed disulfide formation

1 reference

12 December 2020

The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).

1 reference

12 December 2020

Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart Failure

1 reference

12 December 2020

Clinical improvement and hormonal changes in severe cardiac failure after captopril treatment

1 reference

12 December 2020

1 reference

12 December 2020

Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure

1 reference

12 December 2020

Immediate effects of captopril in acute left ventricular failure secondary to myocardial infarction

1 reference

12 December 2020

Renin relationships in congestive cardiac failure, treated and untreated

1 reference

12 December 2020

Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin

1 reference

12 December 2020

Hyperkalemia resulting from captopril administration

1 reference

12 December 2020

Successful low dose captopril rechallenge following drug-induced leucopenia

1 reference

12 December 2020

Taste loss associated with captopril treatment

1 reference

12 December 2020

Reduction of plasma and urinary vasopressin during treatment of severe hypertension by captopril

1 reference

12 December 2020

10.2165/00003495-198325010-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

17 September 2017

0 references

1 reference